Corporate Profile

At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI platform analyzes multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to generate actionable insights for patients with cancer or rare diseases.

Today, over 770 healthcare institutions use our cloud-native, consumption-based SaaS platform to bring the power of data-driven medicine to millions of patients across the globe. Beyond the clinical market, our platform is used by BioPharma partners for AI-powered drug discovery, development, and deployment.

Investor Events
TD Cowen’s 9th Annual FutureHealth Conference
Tuesday, September 10, 2024
3:15pm - 4:00pm EDT
Add to Calendar
Set Email Reminder
Morgan Stanley’s 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024
1:50pm - 2:25pm EDT
SOPHiA GENETICS Second Quarter 2024 Earnings Conference Call
Tuesday, August 6, 2024
8:00am - 9:00am EDT

View all events

Press Releases
Sep 5, 2024
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in development by Boundless Bio BOSTON and ROLLE,...

Sep 4, 2024
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

New generation of SOPHiA DDMTM integrates latest advancements in data processing and technology to deliver elevated experience and capabilities to customers BOSTON and ROLLE, Switzerland, Sept. 4,...

Aug 28, 2024
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced presentations at the 22nd Annual Morgan Stanley Healthcare Conference and the 9th Annual TD...

View all releases

Stock Information

View current and historic stock prices, analyst information, and more

Financial Information

Download quarterly earnings reports, supplementary data, SEC filings, and more

Corporate Governance

Learn about our governance guidelines, code of ethics, Board of Directors, and more

Email Alerts
To opt-in for investor email alerts, please enter your email address. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
* Required Fields
Contact Us

General Inquiries

SOPHiA GENETICS
La Pièce 12, CH-1180
Rolle, Switzerland
+41 21 694 10 60

ir@sophiagenetics.com

Transfer Agent

Computershare Trust Company, N.A.
Courier Delivery:
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
150 Royall St. STE 101
Canton, MA 02021

877.373.6374
www.computershare.com